MRK

Merck & Co., Inc. · Healthcare · Market cap $369.8B

Insiders sold $30.0M net in the last 90 days ·5 sellers, 0 buyers· latest Form 4 filed Aug 13, 2026

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$72.0M

reported sales (SEC code S)

Unique Insiders

11

in the rolling window

Latest filing

Aug 13, 2026

Zachary Jennifer

Merck & Co., Inc. (MRK) has 45 SEC Form 4 filings (91 transaction rows) in the rolling window, disclosed by 11 distinct insiders. Most recent filing: Aug 13, 2026.

Inside the rolling window, 11 insiders at Merck & Co., Inc. reported no open-market purchases and 23 open-market sales totaling $72.0M. The most active filer is EVP, Access, Policy & Comms Guindo Chirfi with 5 filings. Insiders have net sold $30.0M over the trailing 6 months. The most recent open-market filing is a sale of 80,315 shares by EVP, General Counsel Zachary Jennifer, dated Aug 12, 2026, worth $10.7M.

  • Industry:Drug Manufacturers - General
  • CEO:Robert Davis
  • Employees:74,000
  • HQ:Rahway, NJ, US
  • IPO:1978-01-13
Source
Zachary JenniferFirst in 6 months
Sale$10.7MAug 13SEC ↗
Sale$1.4MAug 13SEC ↗
Sale$2.7MAug 12SEC ↗
Sale$1.7MAug 12SEC ↗
Sale$1.5MAug 12SEC ↗
DeLuca Richard R.First in 6 months
Sale$789KAug 10SEC ↗
Maraldo David R.First filing
Sale$2.4MAug 7SEC ↗
Williams David MichaelFirst in 6 months
Sale$6.8MAug 7SEC ↗
Guindo ChirfiFirst in 6 months
Sale$2.0MAug 7SEC ↗
Sale$1.2MFeb 12SEC ↗
Sale$1.2MFeb 10SEC ↗
Zachary JenniferFirst filing
Sale$14.5MFeb 9SEC ↗
Sale$1.2MFeb 9SEC ↗
Li Dean YFirst filing
Sale$1.8MFeb 6SEC ↗
Sale$5.0MFeb 6SEC ↗
Sale$766KFeb 6SEC ↗
Davis Robert MFirst filing
Sale$5.6MFeb 6SEC ↗
Williams David MichaelFirst in 3 months
Sale$610KFeb 6SEC ↗
Guindo ChirfiFirst filing
Sale$2.4MFeb 6SEC ↗
Sale$1.8MFeb 6SEC ↗
DeLuca Richard R.First filing
Sale$4.6MFeb 6SEC ↗
Downing Cristal NFirst filing
Sale$616KNov 12SEC ↗
Sale$720KNov 4SEC ↗
Showing 1–23 of 23
1 / 1

Earnings: last 7 quarters

EstimatedActual

Congress trading MRK 264 all-time

  • RRep. Maria Elvira SalazarSale$1,001 - $15,0002026-09-24
  • RRep. Maria Elvira SalazarPurchase$15,001 - $50,0002026-08-19
  • RRep. Maria Elvira SalazarPurchase$15,001 - $50,0002026-08-19
  • RRep. Maria Elvira SalazarPurchase$15,001 - $50,0002026-08-19
  • DRep. Ro KhannaPurchase$15,001 - $50,0002026-08-07
  • RRep. Keith SelfSale$1,001 - $15,0002025-01-10

STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.

Frequently asked questions

How many SEC Form 4 insider filings does MRK have?

Merck & Co., Inc. (MRK) has 45 SEC Form 4 filings (91 transaction rows) in the rolling 365-day window, disclosed by 11 distinct insiders. Most recent filing: Aug 13, 2026.

When was the most recent SEC Form 4 filing for MRK?

The most recent Form 4 filing for MRK on Tracefour is dated Aug 13, 2026.

Who is the most active insider at MRK?

The most active SEC Form 4 filer at MRK in the rolling window is EVP, Access, Policy & Comms Guindo Chirfi, with 5 filings.

What is the net insider flow at MRK over the last 6 months?

Over the trailing 180 days, insiders at MRK have net sold $30.0M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at MRK in the current window?

Inside the rolling window, insiders at MRK bought $0 and sold $72.0M based on SEC Form 4 filings.

Can I get alerts for MRK insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Merck & Co., Inc. (MRK). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Merck & Co., Inc. is in the Healthcare sector.